Dato’ Dr Mohamed Ibrahim Bin Dato’ Hj. Abdul Wahid business logo picture

Dato’ Dr Mohamed Ibrahim Bin Dato’ Hj. Abdul Wahid


Background
Claim business

Dato’ Dr Mohamed Ibrahim A Wahid has been a Consultant Clinical Oncologist for more than 17 years. He is President of the Malaysian Oncological Society and President of Asian and Pacific Federation of Organization for Cancer Research and Control. He has been involved in several clinical trials in the country. He set up the cancer unit at University Malaya Medical Centre (UMMC) and became Head of Clinical Oncology of the cancer unit. He is a member of American Society of Therapeutic Radiology Oncology (ASTRO) and American Society of Clinical Oncology (ASCO). He is also committee member for expert committee for clinical good practice for breast cancer and advisory panel for Ministry Of Health, Malaysia and international pharmaceuticals company. He was completed his fellowship in Oncology at , Dr Danial Dan Hoed Cancer Centre, Rotterdam Holland, MD Anderson Cancer Centre, Stanford University Medical School and Loyola University Cancer Centre USA. He is also international speaker in oncology and had published many clinical publications in the international journal.

  • Consultant Clinical Oncologist
  • English, Bahasa Melayu, Bahasa Indonesia

Specialisation

  • CyberKnife Radiosurgery & SBRT, IMRT/ IGRT
  • Interest in Lung, Colorectal, Breast, Head & Neck and Urology Cancer
  • Systemic therapy for cancer treatment including Chemotherapy, Targeted therapy & Immunotherapy.

Awards and Achievements

  • Excellence Service Award from University Malaya Medical centre.
  • Over 40 publications, journals, local and international conferences  in Oncology.
  • Active participation in Phase 2 and Phase 3 clinical trials in Breast Cancer, Renal Cell Cancer, Lung Cancer and Head and Neck Cancer.
  • Key Opinion Leader & speaker for international and regional conferences.

Memberships and Associations

  • Vice President in College of Radiology.
  • Past President of the Malaysian Oncology Society.
  • Past President of the Asia Pacific Federation of Cancer Research and Control (APFOCC).
  • Past President of South East Asia Radiology Oncology Group (SEAROG) from 2011 to 2013.
  • International Association for the Study of Lung Cancer (IASLC)  –  Regent for South East Asia.
  • Member of the American Society of Therapeutic Radiology Oncology (ASTRO).

Service /Price Details

 

Day Time
Monday 9.00 am - 1.00 pm
2.00 pm - 6.00 pm
Tuesday 9.00 am - 1.00 pm
2.00 pm - 6.00 pm
Wednesday 2.00 pm - 6.00 pm
Thursday 9.00 am - 1.00 pm
2.00 pm - 6.00 pm
Friday 9.00 am - 1.00 pm
2.00 pm - 6.00 pm

Location

Suite No / Floor Contact
Suite No. 6 (OPD 2, Level 3) +603 - 7620 7979 / +603 - 7787 2992 (Ext: 2868)
Reviewer profile
3.7
  • Experienced
  • Friendly
  • Value of Money
  • Waiting Time
马来西亚癌症基因专家兼肿瘤医药顾问拿督莫哈末依布拉欣医生坦言,在精准医疗(Precision Medicine)之前的癌症常规疗法选项,仅仅是大层面的检测,比如乳腺,肺部,肝脏或淋巴等肿瘤位置,未必能提供准确而精细的检测结果。他说,人体的血液,其他体液,组织或器官等各个部位和层面,都有不同的生物标记,不同疾病的细胞也有不同的生物标记,比如心脏,多发性硬化症及其他疾病,通过肿瘤分子的生物标记,可加强医疗人员掌握药物代谢,药物反应,疗效和安全性的知识,以及病情变化进程。
by
Reviewer profile
3.6
  • Experienced
  • Friendly
  • Value of Money
  • Waiting Time
Menurut Dato' Dr Mohamed Ibrahim, takrifan kanser merujuk kepada sel abnormal yang mengalami gandaan atau pertumbuhan yang berlaku secara tidak terkawal dan melampau dalam tubuh badan manusia dan membentuk tumor. Beliau berkata, jika selama ini kanser paru-paru dikaitkan dengan individu yang merokok, tetapi hari ini bukan lagi satu-satunya punca utama penyakit ini malah semua orang berisiko tinggi untuk menghidapnya.
by